Carotid Endarterectomy and Carotid Angioplasty Stenting as Complementary Treatment Methods: Three Years Experience

Czech version

Authors: V. Přibáň ¹; J. Fiedler ¹; L. Baránková ¹; M. Bombic ¹; L. Štěrba ²
Authors‘ workplace: neurochirurgické oddělení, radiodiagnostické oddělení Nemocnice České Budějovice ¹
Published in: Cesk Slov Neurol N 2008; 71/104(1): 75-80
Category: Short Communication

Overview

Aim:
Carotid artery angioplasty with stenting (CAS) is relatively new interventional technique in secondary prevention of brain ischemia. In comparison with carotid endarterectomy (CEA) indications of CAS are not unambiguously established. The aim of our study was retrospective comparison of 30-d neurological morbidity/mortality of elective CAS and CEA in our department during 3 year period.

Methods:
In 1. 2003 - 10. 2006 were performed 481 elective interventions in our institution: 391 CEA and 90 CAS. CAS indications were: ICA restenosis, comorbid conditions, radiation-induced stenosis and difficult acces surgically. Pre-operative symptoms were congruent in both groups.

Results:
30-d neurological morbidity in CEA group was 1.5%, mortality was recorded in 0.3%. In CEA group was neurological morbidity present in 2.2%, mortality has not been recorded.

Conclusion:
30-d morbidity/mortality in CAS group in above mentioned indications was comparable with CEA group. Authors thus consider CAS in indications of carotid restenosis, radiation-induced stenosis, medical conditions and anatomical reasons legitimate.The results are in conformity with AHA/ASA Guidelines.

Key words:
carotid endarterectomy, carotid artery stenting, complementarity

Sources

1. North American Symptomatic Carotid Endarterectomy Trial Collaborators. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. N Eng J Med 1998; 339: 1415-1425.

2. European Carotid Surgery Trialists Collaborative Group. European carotid surgery trial: interim results for symptomatic patients with severe (70-99%) or with mild (0-29%) carotid stenosis. Lancet 1991; 337: 1235-1243.

3. Asymptomatic Carotid Artery Atherosclerosis Study Group. Endarterectomy for Asymptomatic Carotid Artery Stenosis. JAMA 1995; 273: 1421-1428.

4. MRC Asymptomatic Carotid Surgery Trial (ACST) Collaborative Group. Prevention of disabling and fatal strokes by succesfull carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial. Lancet 2004; 363: 915 - 924.

5. AHA/ASA Guidelines. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack. Stroke 2006; 37: 577-654.

6. Přibáň V, Tesařík R. Karotická mikroendarterektomie ve stáří. Rozhl Chir 2002; 1: 30-33.

7. Mathias K. Ein neuartiges Kathetersystem zur perkutanen transluminalen Angioplastie von Karotisstenosen. Fortschr Med 1977; 95: 1007-11.

8. Rabkin I, Germashev VG. Five-year experience with roentgenologically controlled endovascular nitinol prosthesis. Kardiologia 1990; 30: 11-17 (v ruštině).

9.Théron JG, Payelle GG, Coskun O, Huet HF, Guimaraens L et al. Carotid artery stenosis: treatment with protected balloon angioplasty and stent placement. Radiology 1996; 201: 627-36.

10 Yadav JS, Roubin GS, Iyer SS, Jains S, Blackwell W, Vitek JJ et al. Application of lessons learned from cardiac interventional techniques to carotid angioplasty. J Am Col Cardiol 1995; 25: 380.

11. Henry M, Amor M, Henry I, Klonaris C, Chati Z, Masson I et al. Carotid stenting with cerebral protection: first clinical experience using Percu-Surge guard wire system. J Endovasc Surg 1999; 6: 321-331.

12. CAVATAS investigators. Endovascular versus surgical treatment in patients with carotid stenosis in Carotid and Vertebral Artery Transluminar Angioplasty Study (CAVATAS): a randomised trial. Lancet 2001; 357: 1729-1737.

13. Yadav JS, Wholey MH, Kuntz RE, Fayad P, Katzen BT, Mishkel GJ et al. Stenting and Angioplasty with Protection in Patients and High Risk for Endarterectomy (SAPPHIRE). N Eng J Med 2004; 351: 1565-1567.

14 Mas JL, Chatellier G, Beyssen B, Branchereau A, Moulin T, Becquemin JP et al. Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis. N Engl J Med 2006; 355: 1726-1729.

15. SPACE Collaborative Group. 30 day results from the SPACE trial of stent-protected angioplasty versus carotid endarterectomy in symptomatic patients: a randomised non-inferiority trial. Lancet 2006; 368: 1239-1247.

16. Hobson RW. Carotid Revascularization Endarterectomy versus Stent (CREST). Semin Vasc Surg 2000; 13: 139-143.

17. Vítek JJ, Iyer SS, Roubin GS. Endovaskulární léčba karotických stenóz. In: Krajina A, Peregrin JH. Intervenční radiologie: miniinvazivní terapie. Hradec Králové: Auris; 2005: 355-371.

18. Sundt TM, Piepgras DG, Ebersold MJ, Marsh WR, Fode NC. Risk factors and operative results. In: Sundt TM (ed). Occlusive cerebrovascular disease. Diagnosis and surgical management. Philadelphia: WB Saunders Company 1987: 226-231.